Magee Thomson Investment Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-40,670
| Closed | -$4.75M | – | 105 |
|
|
2016
Q2 | $4.75M | Sell |
40,670
-4,540
| -10% | -$530K | 1.66% | 26 |
|
|
2016
Q1 | $6.3M | Sell |
45,210
-920
| -2% | -$128K | 1.99% | 27 |
|
|
2015
Q4 | $8.8M | Buy |
46,130
+540
| +1% | +$103K | 2.42% | 25 |
|
|
2015
Q3 | $7.13M | Sell |
45,590
-32,760
| -42% | -$5.12M | 2.2% | 25 |
|
|
2015
Q2 | $14.2M | Sell |
78,350
-8,810
| -10% | -$1.59M | 4.11% | 4 |
|
|
2015
Q1 | $15.1M | Sell |
87,160
-2,100
| -2% | -$364K | 3.65% | 13 |
|
|
2014
Q4 | $16.5M | Buy |
89,260
+11,990
| +16% | +$2.22M | 4.11% | 7 |
|
|
2014
Q3 | $12.8M | Sell |
77,270
-52,950
| -41% | -$8.78M | 3.16% | 13 |
|
|
2014
Q2 | $20.3M | Sell |
130,220
-10,580
| -8% | -$1.65M | 4.97% | 2 |
|
|
2014
Q1 | $21.4M | Sell |
140,800
-1,468
| -1% | -$223K | 4.86% | 3 |
|
|
2013
Q4 | $18.9M | Sell |
142,268
-32,050
| -18% | -$4.26M | 4.18% | 4 |
|
|
2013
Q3 | $20.2M | Sell |
174,318
-3,500
| -2% | -$407K | 4.07% | 6 |
|
|
2013
Q2 | $16.4M | Buy |
+177,818
| New | +$16.4M | 3.73% | 8 |
|